Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759323 | PMC |
| http://dx.doi.org/10.1016/j.jacc.2017.07.795 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Estimating the benefits of personalised glycaemic control - Authors' reply.
Lancet
August 2025
Clinical and Biomedical Sciences, Medical School, University of Exeter, Exeter EX1 2HZ, UK. Electronic address:
More than a rebuttal: a field guide to letters to the editor in radiology.
Eur J Radiol
August 2025
Division of Image Statistics, Tohoku Medical Megabank Organization, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8573, Japan. Electronic address:
Letters to the Editor (LTEs) provide an important platform for academic communication. They enable researchers to engage with recently published studies, share their opinions, and contribute to the ongoing discussions in their fields. While traditionally viewed as rebuttal-type responses to target articles, LTEs can be written in more flexible formats, including matchmaking-type, agreement/praise-type, building-upon-type, independent-type, and case report-type LTEs.
View Article and Find Full Text PDFAuthor Reply to The Semaglutide Paradox in Non-Overweight Diabetes: A Benefit Without Explanation.
Eur Heart J Qual Care Clin Outcomes
August 2025
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
In Reply: Dynamic Tumor In Situ Fluid Circulating Tumor DNA Postsurgery Effectively Predicts Recurrence and Clinical Benefits for Glioblastomas.
Neurosurgery
August 2025
Department of Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, China.
Reply: Are Benefits of Early Ezetimibe Conferred by its Effect on LDL-C?
J Am Coll Cardiol
July 2025
Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Centre, Uppsala, Sweden.